Rising temperatures, pollution, and extreme weather are fueling kidney disease and urological cancers—while carbon-heavy medical treatments add to the problem....
Kidney Healthcare
In the UK, more than 3 million people live with moderate to severe chronic kidney disease (stages 3-5). People with...
Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of...
Eledon Pharmaceuticals Inc.’s drug tegoprubart played a key role in the success of the second-ever kidney transplant from a genetically...
VSee Health (NASDAQ: VSEE) has secured a $200K enterprise contract with a leading kidney care...
Key TakeawaysNew data show that GLP1-RA meds like semaglutide can help slow the progression of chronic kidney diseaseThe meds outperformed...
